The lack of effect on NFκB signalling, paralleled by absence of an apoptotic response to aspirin in non-CRC lines, strongly suggests a molecular rationale for the particular protective effect of NSAIDs against CRC. This evidence concerns the gene NFKB1 and colorectal carcinoma.